Home
Bios Fund II NT, 10% Owner: Lantern Pharma LTRN Sell · Filed 24/01/19
Trade details
- Type
- Insider sale
- Amount
- $171,750.6
- Shares · price
- 40,893 sh · $4.20 a share
- Held after
- 550,143 sh
- Stock
- Lantern Pharma LTRN
- Person
- Bios Fund II NT10% Owner
- Trade date
- 24/01/17
- Filed
- 24/01/19
- Days to filing
- 2 days
Sold 6.9% of holdings
- Share of holding sold
- 6.9%
Lantern Pharma trades, last 26 weeks
What else happened in Lantern Pharma around then
Filed or reported within 30 days of the trade day · 23/12/18~24/02/16Bios Fund II NT's recent trades
- Bios Fund II NT
BuyActuate Therapeutics
BuyActuate Therapeutics
ACTU
$500K
71,428 sh
$500K
Filed 25/06/30
Traded 25/06/27
- Bios Fund II NT
SellLantern Pharma
SellLantern Pharma
LTRN
$43.9K
14,218 sh
$43.9K
Filed 25/06/13
Traded 25/06/13
- Bios Fund II NT
SellLantern Pharma
SellLantern Pharma
LTRN
$38.1K
12,319 sh
$38.1K
Filed 25/06/13
Traded 25/06/13
- Bios Fund II NT
SellLantern Pharma
SellLantern Pharma
LTRN
$22.3K
7,206 sh
$22.3K
Filed 25/06/13
Traded 25/06/13
- Bios Fund II NT
SellLantern Pharma
SellLantern Pharma
LTRN
$13.5K
4,354 sh
$13.5K
Filed 25/06/13
Traded 25/06/13
